DUSP3 and non-small cell lung carcinoma: In line with these findings, Min Gyu Lee’s group reported recently that DUSP3 downregulation in NSCLC tumors, when correlated with high levels of the histone H3 lysine 36 (H3K36) demethylase, KDM2A, is associated with poor prognosis for the patients [15].